Back to results

Novel melanoma antigens

The invention relates to melanoma antigen named MELOE and their use for preventing, treating and diagnosing melanoma.

More information (PDF)

Keywords: Melanoma, antigen, peptide, MELOE-1, MELOE-2

Patent Application number: WO2010026165
PCT/EP2019/059421

Inventors:

Nathalie LABARRIERE Agnès MOREAU-AUBRY Yann GODET

Publications:

Oncoimmunology 2019 : Cancer Vaccines: Designing Artificial Synthetic Long Peptides to Improve Presentation of Class I and Class II T Cell Epitopes by Dendritic Cells J Exp Med. 2008 205 (11) 2673-82 Cancer Immunol Immunother 2011 60 (3) 327-37 Eur. J. Immunol. 2010. 40: 1786–94 PLoS One. 2013; 8(9): e75421

Reference:

BIO08305-T1